메뉴 건너뛰기




Volumn 34, Issue 11, 2014, Pages 6705-6710

Circulating tumor cells as a biomarker predictive of sensitivity to docetaxel chemotherapy in patients with castration-resistant prostate cancer

Author keywords

Biomarker; Castration resistant prostate cancer; Circulating tumor cells; Docetaxel

Indexed keywords

ALKALINE PHOSPHATASE; DEXAMETHASONE; DOCETAXEL; HEMOGLOBIN; LACTATE DEHYDROGENASE; PROSTATE SPECIFIC ANTIGEN; SERUM ALBUMIN; ANTINEOPLASTIC AGENT; TAXOID; TUMOR MARKER;

EID: 84916204969     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (46)

References (23)
  • 2
    • 75149172293 scopus 로고    scopus 로고
    • The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
    • Armstrong AJ, Tannock IF, de Wit R, George DJ, Eisenberger M and Halabi S: The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival. Eur J Cancer 46(3): 517-525, 2010.
    • (2010) Eur J Cancer , vol.46 , Issue.3 , pp. 517-525
    • Armstrong, A.J.1    Tannock, I.F.2    De Wit, R.3    George, D.J.4    Eisenberger, M.5    Halabi, S.6
  • 3
    • 6044259206 scopus 로고    scopus 로고
    • Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
    • Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20): 6897-6904, 2004.
    • (2004) Clin Cancer Res , vol.10 , Issue.20 , pp. 6897-6904
    • Allard, W.J.1    Matera, J.2    Miller, M.C.3    Repollet, M.4    Connelly, M.C.5    Rao, C.6    Tibbe, A.G.7    Uhr, J.W.8    Terstappen, L.W.9
  • 5
    • 62849099048 scopus 로고    scopus 로고
    • Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: A reanalysis of IMMC38 trial data
    • Scher HI, Jia X, de Bono JS, Fleisher M, Pienta KJ, Raghavan D and Heller G: Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 10(3): 233-239, 2009.
    • (2009) Lancet Oncol , vol.10 , Issue.3 , pp. 233-239
    • Scher, H.I.1    Jia, X.2    De Bono, J.S.3    Fleisher, M.4    Pienta, K.J.5    Raghavan, D.6    Heller, G.7
  • 10
    • 50949132840 scopus 로고    scopus 로고
    • Immunomagnetic quantification of circulating tumors cell as a prognostic factor of androgen-deprivation responsiveness in hormone-naive metastatic prostate cancer patients
    • Okegawa T, Nutahara K and Higashihara E: Immunomagnetic quantification of circulating tumors cell as a prognostic factor of androgen-deprivation responsiveness in hormone-naive metastatic prostate cancer patients. J Urol 180(4): 1342-1347, 2008.
    • (2008) J Urol , vol.180 , Issue.4 , pp. 1342-1347
    • Okegawa, T.1    Nutahara, K.2    Higashihara, E.3
  • 11
    • 0023834161 scopus 로고    scopus 로고
    • Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
    • Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S and Moinuddin M: Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61( 1): 195-202, 1998.
    • (1998) Cancer , vol.61 , Issue.1 , pp. 195-202
    • Soloway, M.S.1    Hardeman, S.W.2    Hickey, D.3    Raymond, J.4    Todd, B.5    Soloway, S.6    Moinuddin, M.7
  • 12
    • 3242742186 scopus 로고    scopus 로고
    • The natural history of androgen-independent prostate cancer
    • Shulman MJ and Benaim EA: The natural history of androgen-independent prostate cancer. J Urol 172(1): 141-145, 2004.
    • (2004) J Urol , vol.172 , Issue.1 , pp. 141-145
    • Shulman, M.J.1    Benaim, E.A.2
  • 13
    • 17144426134 scopus 로고    scopus 로고
    • Circulating tumor cells predict survival in patients with metastatic prostate cancer
    • Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG and Terstappen LW: Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 65(4): 713-718, 2005.
    • (2005) Urology , vol.65 , Issue.4 , pp. 713-718
    • Moreno, J.G.1    Miller, M.C.2    Gross, S.3    Allard, W.J.4    Gomella, L.G.5    Terstappen, L.W.6
  • 17
    • 59349109415 scopus 로고    scopus 로고
    • Prognostic significance of circulating tumor cells in patients with hormone-refractory prostate cancer
    • Okegawa T, Nutahara K and Higashihara E: Prognostic significance of circulating tumor cells in patients with hormone-refractory prostate cancer. J Urol 181(3): 1091-1097, 2009.
    • (2009) J Urol , vol.181 , Issue.3 , pp. 1091-1097
    • Okegawa, T.1    Nutahara, K.2    Higashihara, E.3
  • 19
    • 79959269553 scopus 로고    scopus 로고
    • Circulating tumor cells as biomarkers in prostate cancer
    • Danila DC, Fleisher M, Scher HI: Circulating tumor cells as biomarkers in prostate cancer. Clin Cancer Res 17(12): 3903-3912, 2011.
    • (2011) Clin Cancer Res , vol.17 , Issue.12 , pp. 3903-3912
    • Danila, D.C.1    Fleisher, M.2    Scher, H.I.3
  • 20
    • 80053299958 scopus 로고    scopus 로고
    • TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
    • Danila DC, Anand A, Sung CC, Heller G, Leversha MA, Cao L, Lilja H, Molina A, Sawyers CL, Fleisher M and Scher HI: TMPRSS2-ERG status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate. Eur Urol 60( 5): 897-904, 2011.
    • (2011) Eur Urol , vol.60 , Issue.5 , pp. 897-904
    • Danila, D.C.1    Anand, A.2    Sung, C.C.3    Heller, G.4    Leversha, M.A.5    Cao, L.6    Lilja, H.7    Molina, A.8    Sawyers, C.L.9    Fleisher, M.10    Scher, H.I.11


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.